Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Redefining the molecular rejection states in 3230 heart transplant biopsies: Relationships to parenchymal injury and graft survival

PF. Halloran, K. Madill-Thomsen, AZ. Aliabadi-Zuckermann, M. Cadeiras, MG. Crespo-Leiro, EC. Depasquale, M. Deng, J. Gökler, S. Hall, A. Jamil, DH. Kim, J. Kobashigawa, P. Macdonald, V. Melenovsky, J. Patel, L. Potena, K. Shah, J. Stehlik, A. Zuckermann

. 2024 ; 24 (8) : 1414-1426. [pub] 20240326

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24019606

The first-generation Molecular Microscope (MMDx) system for heart transplant endomyocardial biopsies used expression of rejection-associated transcripts (RATs) to diagnose not only T cell-mediated rejection (TCMR) and antibody-mediated rejection (ABMR) but also acute injury. However, the ideal system should detect rejection without being influenced by injury, to permit analysis of the relationship between rejection and parenchymal injury. To achieve this, we developed a new rejection classification in an expanded cohort of 3230 biopsies: 1641 from INTERHEART (ClinicalTrials.gov NCT02670408), plus 1589 service biopsies added to improve the power of the machine learning algorithms. The new system used 6 rejection classifiers instead of RATs and generated 7 rejection archetypes: No rejection, 48%; Minor, 24%; TCMR1, 2.3%; TCMR2, 2.7%; TCMR/mixed, 2.7%; early-stage ABMR, 3.9%; and fully developed ABMR, 16%. Using rejection classifiers eliminated cross-reactions with acute injury, permitting separate assessment of rejection and injury. TCMR was associated with severe-recent injury and late atrophy-fibrosis and rarely had normal parenchyma. ABMR was better tolerated, seldom producing severe injury, but in later biopsies was often associated with atrophy-fibrosis, indicating long-term risk. Graft survival and left ventricular ejection fraction were reduced not only in hearts with TCMR but also in hearts with severe-recent injury and atrophy-fibrosis, even without rejection.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24019606
003      
CZ-PrNML
005      
20241024110608.0
007      
ta
008      
241015s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ajt.2024.03.031 $2 doi
035    __
$a (PubMed)38527588
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Halloran, Philip F $u Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. Electronic address: phallora@ualberta.ca
245    10
$a Redefining the molecular rejection states in 3230 heart transplant biopsies: Relationships to parenchymal injury and graft survival / $c PF. Halloran, K. Madill-Thomsen, AZ. Aliabadi-Zuckermann, M. Cadeiras, MG. Crespo-Leiro, EC. Depasquale, M. Deng, J. Gökler, S. Hall, A. Jamil, DH. Kim, J. Kobashigawa, P. Macdonald, V. Melenovsky, J. Patel, L. Potena, K. Shah, J. Stehlik, A. Zuckermann
520    9_
$a The first-generation Molecular Microscope (MMDx) system for heart transplant endomyocardial biopsies used expression of rejection-associated transcripts (RATs) to diagnose not only T cell-mediated rejection (TCMR) and antibody-mediated rejection (ABMR) but also acute injury. However, the ideal system should detect rejection without being influenced by injury, to permit analysis of the relationship between rejection and parenchymal injury. To achieve this, we developed a new rejection classification in an expanded cohort of 3230 biopsies: 1641 from INTERHEART (ClinicalTrials.gov NCT02670408), plus 1589 service biopsies added to improve the power of the machine learning algorithms. The new system used 6 rejection classifiers instead of RATs and generated 7 rejection archetypes: No rejection, 48%; Minor, 24%; TCMR1, 2.3%; TCMR2, 2.7%; TCMR/mixed, 2.7%; early-stage ABMR, 3.9%; and fully developed ABMR, 16%. Using rejection classifiers eliminated cross-reactions with acute injury, permitting separate assessment of rejection and injury. TCMR was associated with severe-recent injury and late atrophy-fibrosis and rarely had normal parenchyma. ABMR was better tolerated, seldom producing severe injury, but in later biopsies was often associated with atrophy-fibrosis, indicating long-term risk. Graft survival and left ventricular ejection fraction were reduced not only in hearts with TCMR but also in hearts with severe-recent injury and atrophy-fibrosis, even without rejection.
650    12
$a transplantace srdce $x škodlivé účinky $7 D016027
650    12
$a rejekce štěpu $x etiologie $x diagnóza $x patologie $7 D006084
650    _2
$a lidé $7 D006801
650    12
$a přežívání štěpu $7 D006085
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a biopsie $7 D001706
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé středního věku $7 D008875
650    _2
$a následné studie $7 D005500
650    _2
$a prognóza $7 D011379
650    _2
$a myokard $x patologie $7 D009206
650    _2
$a dospělí $7 D000328
650    _2
$a rizikové faktory $7 D012307
655    _2
$a časopisecké články $7 D016428
700    1_
$a Madill-Thomsen, Katelynn $u Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
700    1_
$a Aliabadi-Zuckermann, Arezu Z $u Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria
700    1_
$a Cadeiras, Martin $u Ronald Reagan UCLA Medical Center, Los Angeles, California, USA
700    1_
$a Crespo-Leiro, Marisa G $u Advanced Heart Failure and Heart Transplant Unit, Complexo Hospitalario Universitario A Coruña, A Coruña, Spain
700    1_
$a Depasquale, Eugene C $u Ronald Reagan UCLA Medical Center, Los Angeles, California, USA
700    1_
$a Deng, Mario $u Ronald Reagan UCLA Medical Center, Los Angeles, California, USA
700    1_
$a Gökler, Johannes $u Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria
700    1_
$a Hall, Shelley $u Baylor Scott & White Health, Dallas, Texas, USA
700    1_
$a Jamil, Aayla $u Baylor Scott & White Health, Dallas, Texas, USA
700    1_
$a Kim, Daniel H $u Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
700    1_
$a Kobashigawa, Jon $u Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA
700    1_
$a Macdonald, Peter $u The Victor Chang Cardiac Research Institute, Sydney, Australia
700    1_
$a Melenovsky, Vojtech $u Department of Cardiology, Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic
700    1_
$a Patel, Jignesh $u Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA
700    1_
$a Potena, Luciano $u Heart Failure and Transplant Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
700    1_
$a Shah, Keyur $u Department of Cardiology, Virginia Commonwealth University, Richmond, Virginia, USA
700    1_
$a Stehlik, Josef $u Department of Medicine, University of Utah, Salt Lake City, Utah, USA
700    1_
$a Zuckermann, Andreas $u Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria
773    0_
$w MED00006447 $t American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons $x 1600-6143 $g Roč. 24, č. 8 (2024), s. 1414-1426
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38527588 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241015 $b ABA008
991    __
$a 20241024110602 $b ABA008
999    __
$a ok $b bmc $g 2202065 $s 1231579
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 24 $c 8 $d 1414-1426 $e 20240326 $i 1600-6143 $m American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons $n Am J Transplant $x MED00006447
LZP    __
$a Pubmed-20241015

Najít záznam

Citační ukazatele

Možnosti archivace